SCHEMBL7658362

SCHEMBL7658362

CC(C)(C)OC(=O)ON=C(N)c1ccc(N)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.49
ELANE P08246 1/20 0.46
TNF P01375 1/20 0.46
KLF5 Q13887 1/20 0.46
NOD1 Q9Y239 1/20 0.46
NPC1 O15118 9/20 0.42
RAB9A P51151 9/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
POLB P06746 1/20 0.41
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
MAPT P10636 2/20 0.39
ATM Q13315 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10173004 0.85 TNF (0.57) USP2TNFKLF5NOD1NPC1
SCHEMBL7284589 0.78 TNF (0.50) USP2TNFKLF5NOD1NPC1
SCHEMBL28625201 0.75 LMNA (0.49) ELANENPC1RAB9ALMNAMAPT
SCHEMBL2366870 0.74 ELANE (0.68) ELANENPC1RAB9AHPGDMAPT
SCHEMBL380152 0.73 CA12 (0.57) ELANENPC1RAB9ALMNAMAPT
SCHEMBL8377878 0.72 TNF (0.50) TNFKLF5NOD1NPC1RAB9A
Methane SCHEMBL28278848 0.72 CA12 (0.56) ELANENPC1RAB9ALMNAMAPT
SCHEMBL6650000 0.71 MASP2 (0.43) NPC1RAB9ASMN1; SMN2L3MBTL1LMNA
SCHEMBL18070439 0.70 PARP10 (0.47) USP2NPC1RAB9ASMN1; SMN2L3MBTL1
Nitrogen SCHEMBL27824368 0.70 CA12 (0.54) ELANENPC1RAB9ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed